Notice on the Allotment of Stock Options (Stock Acquisition Rights)
|
|
June 25, 2008, Osaka, Japan - Santen Pharmaceutical Co., Ltd announces that the details of the stock acquisition rights to be issued as stock options pursuant to provisions under Articles 238, etc. of the Corporations Act were approved at the 96th general meeting of shareholders of the Company at the meeting of the Board of Directors held today.
In addition, the exercise price of the stock option and other points to be assigned will be determined on the issue date of the stock option, July 2, 2008. |
| |
| 1. |
Issue date of stock option |
| July 2, 2008 |
|
| 2. |
Person to whom stock options will be granted |
| 4 directors and 8 corporate officers |
|
| 3. |
Total stock options to be issued |
| 1,617 options |
|
| 4. |
Price of the stock Option |
| Granted free of charge |
|
| 5. |
Aggregate amount of common stock to be issued upon exercise of the stock option |
| To be determined on July 2, 2008 |
|
| 6. |
Type and number of shares subject to the proposed stock option |
| 161,700 shares of the Company's common stock |
|
| 7. |
Exercise Price of the Stock Option |
| To be determined on July 2, 2008 |
|
| 8. |
Exercise Period of Stock Option |
| From June 28, 2010 to June 25, 2018 |
|
| 9. |
Amount of the portion of the issue price of the share to be issued upon exercise of the stock option which is transferred to paid-in capital |
| To be determined on July 2, 2008 |
|
|
|
|
|
Back to top
|
|
|
|
